Structure of the Varicella Zoster Virus Thymidylate Synthase Establishes Functional and Structural Similarities as the Human Enzyme and Potentiates Itself as a Target of Brivudine.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Antiviral Agents/*metabolism ; Bromodeoxyuridine/*analogs & derivatives ; Herpesvirus 3, Human/*enzymology ; Thymidylate Synthase/*chemistry ; Thymidylate Synthase/*metabolism; Apoenzymes/chemistry ; Apoenzymes/metabolism ; Binding Sites ; Bromodeoxyuridine/metabolism ; Humans ; Models, Molecular ; Phosphorylation ; Protein Binding ; Protein Conformation

Varicella zoster virus (VZV) is a highly infectious human herpesvirus that is the causative agent for chicken pox and shingles. VZV encodes a functional thymidylate synthase (TS), which is the sole enzyme that produces dTMP from dUMP de novo. To study substrate binding, the complex structure of TSVZV with dUMP was determined to a resolution of 2.9 Å. In the absence of a folate co-substrate, dUMP binds in the conserved TS active site and is coordinated similarly as in the human encoded TS (TSHS) in an open conformation. The interactions between TSVZV with dUMP and a cofactor analog, raltitrexed, were also studied using differential scanning fluorimetry (DSF), suggesting that TSVZV binds dUMP and raltitrexed in a sequential binding mode like other TS. The DSF also revealed interactions between TSVZV and in vitro phosphorylated brivudine (BVDUP), a highly potent anti-herpesvirus drug against VZV infections. The binding of BVDUP to TSVZV was further confirmed by the complex structure of TSVZV and BVDUP solved at a resolution of 2.9 Å. BVDUP binds similarly as dUMP in the TSHS but it induces a closed conformation of the active site. The structure supports that the 5-bromovinyl substituent on BVDUP is likely to inhibit TSVZV by preventing the transfer of a methylene group from its cofactor and the subsequent formation of dTMP. The interactions between TSVZV and BVDUP are consistent with that TSVZV is indeed a target of brivudine in vivo. The work also provided the structural basis for rational design of more specific TSVZV inhibitors.

Proc Natl Acad Sci U S A. 1979 Jun;76(6):2947-51. (PMID: 223163)
PLoS One. 2013;8(1):e53851. (PMID: 23382856)
Eur J Cancer. 1995 Jul-Aug;31A(7-8):1277-82. (PMID: 7577036)
Bioorg Chem. 2014 Feb;52:44-9. (PMID: 24321279)
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501. (PMID: 20383002)
Biochemistry. 1990 Jul 31;29(30):6977-86. (PMID: 2223755)
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. (PMID: 19461840)
J Mol Biol. 1990 Aug 20;214(4):923-36. (PMID: 2201778)
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21. (PMID: 20057044)
Biomed Res Int. 2014;2014:945803. (PMID: 24995339)
Nat Rev Microbiol. 2004 Sep;2(9):704-20. (PMID: 15372081)
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67. (PMID: 22505256)
J Synchrotron Radiat. 2007 Jan;14(Pt 1):99-108. (PMID: 17211076)
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10980-4. (PMID: 7479921)
Biochemistry. 1995 Dec 19;34(50):16279-87. (PMID: 8845352)
J Virol. 2002 Oct;76(20):10530-2. (PMID: 12239332)
N Engl J Med. 2000 Mar 2;342(9):635-45. (PMID: 10699164)
Science. 1987 Jan 23;235(4787):448-55. (PMID: 3099389)
Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7376-80. (PMID: 8394020)
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42. (PMID: 21460441)
Ann Oncol. 2004 Jul;15(7):1025-32. (PMID: 15205195)
Protein Sci. 2001 May;10(5):988-96. (PMID: 11316879)
J Clin Virol. 2004 Jun;30(2):115-33. (PMID: 15125867)
J Biol Chem. 1978 Dec 25;253(24):8721-7. (PMID: 214430)
J Mol Biol. 1993 Aug 20;232(4):1101-16. (PMID: 8371269)
Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. (PMID: 18048412)
Nat Rev Drug Discov. 2005 Nov;4(11):928-40. (PMID: 16264436)
Biosci Rep. 2014 Dec 23;34(6):e00168. (PMID: 25423174)
Antimicrob Agents Chemother. 1981 Sep;20(3):420-3. (PMID: 6272634)
Am Fam Physician. 2000 Apr 15;61(8):2437-44, 2447-8. (PMID: 10794584)
Open Biol. 2012 Oct;2(10):120120. (PMID: 23155486)
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16823-8. (PMID: 23035243)
Biochemistry. 1993 Jul 20;32(28):7116-25. (PMID: 8343503)
Structure. 2003 Jun;11(6):677-90. (PMID: 12791256)
Front Microbiol. 2015 Apr 24;6:363. (PMID: 25964781)
Methods Enzymol. 1997;276:307-26. (PMID: 27754618)
Mol Pharmacol. 1987 Sep;32(3):410-6. (PMID: 2823092)
J Clin Oncol. 1985 Mar;3(3):373-8. (PMID: 3973648)
J Synchrotron Radiat. 2002 Nov 1;9(Pt 6):401-6. (PMID: 12409628)
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21. (PMID: 20124702)
J Biol Chem. 2004 Aug 6;279(32):33035-8. (PMID: 15096496)
J Mol Biol. 2001 Nov 2;313(4):813-29. (PMID: 11697906)
Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4276s-4280s. (PMID: 15217974)
J Gen Virol. 1987 May;68 ( Pt 5):1449-55. (PMID: 3033144)
Clin Colorectal Cancer. 2002 Feb;1(4):220-9. (PMID: 12450420)
Mol Pharmacol. 1981 Jul;20(1):230-3. (PMID: 6270535)
Biochim Biophys Acta. 2002 Jul 18;1587(2-3):206-14. (PMID: 12084462)
Nature. 1983 Dec 1-7;306(5942):478-80. (PMID: 6316159)
Biochemistry. 2001 Feb 20;40(7):1897-902. (PMID: 11329255)
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):374-80. (PMID: 20382990)
Cold Spring Harb Perspect Biol. 2012 Sep 01;4(9):a013011. (PMID: 22952399)
J Biol Chem. 2001 Apr 27;276(17):14170-7. (PMID: 11278511)
Pharmacotherapy. 2001 Jan;21(1):11-34. (PMID: 11191730)

0 (Antiviral Agents)
0 (Apoenzymes)
2M3055079H (brivudine)
EC 2.1.1.45 (Thymidylate Synthase)
G34N38R2N1 (Bromodeoxyuridine)

Date Created: 20151203 Date Completed: 20160623 Latest Revision: 20181113

20240829

PMC4668047

10.1371/journal.pone.0143947

26630264